EYLEA HD
Live / Registered — Registered (as of 03 Sept 2024)
What this means for you
Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Sept 2030: the §8 declaration of use).
Record
- Serial number
- 97264271
- Registration number
- 7496066
- Mark type
- Word mark
- Filed
- 11 Feb 2022
- Published for opposition
- 01 Nov 2022
- Registered
- 03 Sept 2024
- Next maintenance filing
- §8 declaration of use, due by 03 Sept 2030 (grace period to 03 Mar 2031)
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Board proceedings on this mark
The owner also pleads this mark in 3 other Board proceedings.
Prosecution history
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Feb 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Feb 2024 — NON-FINAL ACTION E-MAILED
- 12 Feb 2024 — SU - NON-FINAL ACTION - WRITTEN